Cardinal Capital Management Inc (North Carolina)’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,409	Closed	-$347K	–	123
2015 Q2	$347K	Buy	8,409 +1,438	+21%	+$51.6K	0.15%	104
2015 Q1	$246K	Buy	+6,971	New	+$236K	0.1%	107
2013 Q4	–	Sell	-7,280	Closed	-$218K	–	96
2013 Q3	$218K	Buy	7,280 +223	+3%	+$6.2K	0.12%	79
2013 Q2	$203K	Buy	+7,057	New	+$194K	0.12%	80

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s BRLI Position: Q3 2015 in Review

Cardinal Capital Management Inc (North Carolina) sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 8,409 shares — an estimated $347K sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $347K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Cardinal Capital Management Inc (North Carolina) reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Cardinal Capital Management Inc (North Carolina) sold 8,409 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $347K.
Cardinal Capital Management Inc (North Carolina) first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
Cardinal Capital Management Inc (North Carolina)'s BIO-REFERENCE LABS INC-NEW- position peaked at $347K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q3 2015, filed 23 Oct 2015.